La découverte du bosentan

The discovery of a new medications is always a crucial time for clinicians, particularly when the medication is the first of a new class. In the present interview, Martine Clozel, who discovered bosentan and is one of the founding members of the new pharmaceutical company Actelion, describes the circumstances of her discovery, the central role of endothelin and the clinical perspectives for this medication.